| Stage | ARXS | % of rev | ARMK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $5.1B | 100.00% | ARMK ×8.97 |
| Gross profit | $306M | 54.27% | $5.1B | 100.00% | ARMK +45.7pp |
| Operating income | $133M | 23.66% | $216M | 4.26% | ARXS +19.4pp |
| Pre-tax income | $120M | 21.23% | $136M | 2.68% | ARXS +18.5pp |
| Net income | $84M | 14.84% | $98M | 1.93% | ARXS +12.9pp |
| Stage | ARXS | ARMK | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $5.1B100.00% | ARMK ×8.97 |
| Gross profit | 54.27%$306M | 100.00%$5.1B | ARMK +45.7pp |
| Operating income | 23.66%$133M | 4.26%$216M | ARXS +19.4pp |
| Pre-tax income | 21.23%$120M | 2.68%$136M | ARXS +18.5pp |
| Net income |
| 14.84%$84M |
| 1.93%$98M |
| ARXS +12.9pp |